Y2K-23473-25055
4 vaccinations
2 coded responses
24 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 040 / ME
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-03
Registered in v-safe
-
2021-02-03
Dose 1 — Pfizer-BioNTech
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
-
2021-02-24
Survey response — day 21, dose 1MedDRA: Breast cancer, Chemotherapy, Drug hypersensitivity, Hypersensitivity, Pre-existing disease, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Started chemotherapy for breast cancer...had allergic reaction to cremophor which was the lipid part of Taxol. Because it is similar to the lipid part of the Covid vaccine, I delayed it until I speak with my oncologist. · Healthcare visit (other): In person visit tomorrow and second chemotherapy with new formulaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-03
Survey response — day 28, dose 1MedDRA: Breast cancer, Chemotherapy, Drug hypersensitivity, Medical counselling, Office visit, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Chemotherapy for breast cancer.Had allergic reaction to cremophor. May be similar to coating on mRNA in vaccine. My doctor advised me to delay until more information on this · Healthcare visit (other): Cancer specialistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Report sent to call center — day 28, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-10
- 2021-03-18
-
2021-04-29
Dose 2 — Pfizer-BioNTech
- 2021-08-04
- 2021-08-04
- 2021-08-24
-
2021-09-01
Dose 3 — Pfizer-BioNTech
- 2021-10-28
- 2021-12-01
- 2022-03-02
-
2022-03-24
Dose 4 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-06-23
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech | No |
| 3 | 2021-09-01 | Pfizer-BioNTech | No |
| 4 | 2022-03-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-24 | Unsuccessful | |
| 2021-03-03 | Unsuccessful |
Free text
Release 4 — day 21, dose 1
Symptoms: Started chemotherapy for breast cancer...had allergic reaction to cremophor which was the lipid part of Taxol. Because it is similar to the lipid part of the Covid vaccine, I delayed it until I speak with my oncologist.
Healthcare visit (other): In person visit tomorrow and second chemotherapy with new formula
Release 5 — day 28, dose 1
Symptoms: Chemotherapy for breast cancer.Had allergic reaction to cremophor. May be similar to coating on mRNA in vaccine. My doctor advised me to delay until more information on this
Healthcare visit (other): Cancer specialist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ○ | ✓ | ○ |
| HCVO | Office visit | ✓ | · | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Breast cancer | ✓ | ✓ | ✓ |
| SD | Chemotherapy | ✓ | ✓ | ✓ |
| SD | Drug hypersensitivity | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Medical counselling | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Unevaluable event | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release